Hisamitsu Pharmaceutical Co Inc
TSE:4530
Hisamitsu Pharmaceutical Co Inc
Cash from Investing Activities
Hisamitsu Pharmaceutical Co Inc
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
Cash from Investing Activities
¥4.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Cash from Investing Activities
-¥840.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
13%
|
CAGR 10-Years
-21%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Cash from Investing Activities
-¥201.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-45%
|
CAGR 10-Years
-7%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Cash from Investing Activities
-¥190.5B
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-16%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Cash from Investing Activities
-¥37.3B
|
CAGR 3-Years
28%
|
CAGR 5-Years
13%
|
CAGR 10-Years
-11%
|
|
Astellas Pharma Inc
TSE:4503
|
Cash from Investing Activities
-¥846.4B
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-72%
|
CAGR 10-Years
-31%
|
See Also
What is Hisamitsu Pharmaceutical Co Inc's Cash from Investing Activities?
Cash from Investing Activities
4.5B
JPY
Based on the financial report for Nov 30, 2023, Hisamitsu Pharmaceutical Co Inc's Cash from Investing Activities amounts to 4.5B JPY.